Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, with an initial focus on rare diseases.

Stock Quote

Price

Change

High

View DetailsStock Lookup

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Corporate Presentation

Latest News

May 10, 2021
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2021 Financial Results »

March 11, 2021
Longboard Pharmaceuticals Announces Pricing of Initial Public Offering »

January 21, 2021
Longboard Pharmaceuticals Appoints Brandi L. Roberts as Chief Financial Officer »

Learn More »

Latest Events

Investor events will be posted soon.

Learn More »